Evidence map›Paper›PMID 37674873›Full record

ArticlePulmonary circulation2023

Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survival.

Guillermo Torres, Andrew C Lancaster, Jun Yang, Megan Griffiths, Stephanie Brandal, Rachel Damico, Dhananjay Vaidya, Catherine E Simpson, Lisa J Martin, Michael W Pauciulo and 5 more

Open access · goldAbstract read
In one paragraph

Article in Pulmonary circulation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cellular senescence in adult pulmonary hypertension: current state and future challenges.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Exploring the Molecular Signatures of Pulmonary Vascular Lesions.American journal of respiratory and critical care medicine · 2024
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Guillermo TorresDepartment of Pediatrics, Division of Pediatric Cardiology Johns Hopkins University Baltimore Maryland USA.ORCID 0000-0002-9052-9594
Andrew C LancasterSchool of Medicine Johns Hopkins University Baltimore Maryland USA.
Jun YangDepartment of Pediatrics, Division of Pediatric Cardiology Johns Hopkins University Baltimore Maryland USA.ORCID 0000-0001-9273-4578
Megan GriffithsDepartment of Pediatrics, Division of Pediatric Cardiology University of Texas Southwestern Medical Center Dallas Texas USA.
Stephanie BrandalDepartment of Pediatrics, Division of Pediatric Cardiology Johns Hopkins University Baltimore Maryland USA.
Rachel DamicoDepartment of Medicine, Division of Pulmonary and Critical Care Medicine Johns Hopkins University Baltimore Maryland USA.
Dhananjay VaidyaDepartment of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA.
Catherine E SimpsonDepartment of Medicine, Division of Pulmonary and Critical Care Medicine Johns Hopkins University Baltimore Maryland USA.ORCID 0000-0002-2388-5660
Lisa J MartinDepartment of Pediatrics, Division of Human Genetics, Cincinnati Children's Hospital Medical Center University of Cincinnati College of Medicine Cincinnati Ohio USA.
Michael W PauciuloDepartment of Pediatrics, Division of Human Genetics, Cincinnati Children's Hospital Medical Center University of Cincinnati College of Medicine Cincinnati Ohio USA.
William C NicholsDepartment of Pediatrics, Division of Human Genetics, Cincinnati Children's Hospital Medical Center University of Cincinnati College of Medicine Cincinnati Ohio USA.
David D IvyDepartment of Pediatric Cardiology Children's Hospital Colorado Denver Colorado USA.
Eric D AustinDepartment of Pediatrics, Division of Allergy, Immunology, and Pulmonary Medicine Vanderbilt University Medical Center Nashville Tennessee USA.
Paul M HassounDepartment of Medicine, Division of Pulmonary and Critical Care Medicine Johns Hopkins University Baltimore Maryland USA.
Allen D EverettDepartment of Pediatrics, Division of Pediatric Cardiology Johns Hopkins University Baltimore Maryland USA.
Johns Hopkins University · USCincinnati Children's Hospital Medical Center · USChildren's Hospital Colorado · USThe University of Texas Southwestern Medical Center · USVanderbilt University Medical Center · US

Funding

Pulmonary Hypertension Breakthrough InitiativeR24HL123767 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ALDRED, MICHEALA A, ERZURUM, SERPIL C. · 2014 to 2017
$10.1M
National Biological Sample and Data Repository for PAHR24HL105333 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI NICHOLS, WILLIAM C · 2012 to 2016
$10.1M
Risk stratification in pulmonary arterial hypertension: Intersection of OMICs and longitudinal phenotypes through the PAH BiobankR01HL160941 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI DESAI, ANKIT A, NICHOLS, WILLIAM C · 2022 to 2025
$3.2M
Training for Clinician Scientists in Pediatric Critical Cardiopulmonary DiseaseT32HL125239 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BEMBEA, MELANIA MARIA, EVERETT, ALLEN D · 2015 to 2024
$3.0M
Clinical and mechanistic role of HDGF in pulmonary hypertensionR01HL135114 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI EVERETT, ALLEN D · 2017 to 2020
$2.9M
Role of IGF axis in pulmonary hypertensionR01HL150070 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI EVERETT, ALLEN D, YANG, JUN · 2020 to 2023
$2.8M
The role of xanthine oxidoreductase activity and altered metabolism in scleroderma-associated pulmonary arterial hypertensionK23HL153781 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SIMPSON, CATHERINE · 2020 to 2024
$883k
Circulating biomarkers of IPAH.R03HL110830 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI EVERETT, ALLEN D · 2011 to 2012
$162k
NHLBI NIH HHS K23 HL153781NHLBI NIH HHS R01 HL135114NHLBI NIH HHS R01 HL150070NHLBI NIH HHS R01 HL160941NHLBI NIH HHS R03 HL110830NHLBI NIH HHS R24 HL105333NHLBI NIH HHS R24 HL123767NHLBI NIH HHS T32 HL125239
6 · The paper itself

Abstract

Insulin-like growth factor (IGF) binding proteins (IGFBPs) are a family of growth factor modifiers, some of which are known to be independently associated with pulmonary arterial hypertension (PAH) survival. IGF factor binding protein 7 (IGFBP7) is a unique low-affinity IGFBP that, independent of IGF, stimulates prostacyclin production. This study proposed to establish associations between IGFBP7 and PAH severity and survival, using enrollment and longitudinal samples. Serum IGFBP7 levels were significantly elevated in patients with PAH compared to controls. After adjusting for age and sex, logarithmic increases in IGFBP7 were associated with a 20 m shorter six-minute walk distance (6MWD;

Indexed as

biomarkeroutcomesprognosisproteomics

Identifiers

PMID37674873
PMCPMC10477418
OpenAlexW4386460104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.